| Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283) |
|---|
| 03/07/2002 | WO2002018417A1 Nucleophile-stable thioester generating compounds, methods of production and use |
| 03/07/2002 | WO2002018323A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/07/2002 | WO2002018321A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/07/2002 | US20020028957 Optically active 1,4-benzodioxin-2-carboxylic acid derivatives and process for producing the same |
| 03/07/2002 | US20020028306 Liquid crystals; chemical and heat resistance; photostability |
| 03/07/2002 | CA2416740A1 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/07/2002 | CA2412424A1 Nucleophile-stable thioester generating compounds, methods of production and use |
| 03/06/2002 | EP1184380A1 Ammonium 3,5,6-trihydroxyhexanoate derivatives and preparation process thereof |
| 03/06/2002 | EP1183229A1 Glucagon antagonists/inverse agonists |
| 03/06/2002 | EP0883403A4 Method for treating sexual dysfunctions |
| 03/06/2002 | CN1080251C Dihalopropene compound, insecticide/acaricide containing said dihalopropene compound as active ingredient and intermediate compound for use inproduct of said dihalopropene compounds |
| 02/28/2002 | WO2002016311A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 02/28/2002 | WO2001070720A3 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 02/28/2002 | US20020026065 2-hydroxy-3 - (4-hydroxy-3-sulfonamidophenyl) - propylamines useful as beta 3 adrenergic agonists |
| 02/28/2002 | US20020025965 Antiserotonine agents |
| 02/27/2002 | EP1182186A2 Difluoromethyl ether derivative and process for producing the same |
| 02/27/2002 | EP1181269A1 Cell proliferation inhibitors |
| 02/27/2002 | EP1181263A1 Treatment of a composition comprising a trimethylolalkane bis-monolinear formal |
| 02/27/2002 | CN1337395A Novel acardite compound, its preparation method and medicinal composition containing said compound |
| 02/27/2002 | CN1337387A Method for preparing novel phenol compound divirated from dialkoxy acetaldehyde |
| 02/26/2002 | US6350878 Intermediates for the synthesis of epothilones and methods for their preparation |
| 02/23/2002 | CA2348166A1 Ammonium 3,5,6-trihydroxyhexanoate derivatives and preparation process thereof |
| 02/21/2002 | WO2002014303A1 Process for the preparation of cyclic esters and method for purification of the same |
| 02/21/2002 | DE10134299A1 New stable mesogenic tetrafluoroethylene-bridged dioxane derivatives, useful in liquid crystal displays, especially of the TFT or STN type |
| 02/20/2002 | CN1336912A Novel propargylether derivatives |
| 02/20/2002 | CN1336371A Dibenzo-1,3-dioxo-cyclooctane-2-oximino carboxylate compound with herbicidal activity |
| 02/19/2002 | US6348592 Method of making dihydroperimidine squaraine compounds |
| 02/19/2002 | US6348244 Liquid-crystal compounds having large negative value of permittivity anisotropy, liquid-crystal composition, and liquid-crystal display element |
| 02/14/2002 | WO2002012534A2 Bio-intermediates for use in the chemical synthesis of polyketides |
| 02/14/2002 | WO2001051479A3 Tricyclic compounds with antiviral activity |
| 02/14/2002 | US20020019389 3-(N-(5,6-dimethyl-2-methoxypyridin-3-yl)aminocarbonyl)-7,8-dimethoxy-1-phenyl-2,3,4,5-tetrahydro-3H-benzazepine, for example |
| 02/14/2002 | US20020019380 1-(6-((dimethylamino)methyl)-1-methyl-2,3,5,6-tetrahydro-1H -cyclobuta(f)indol-6-yl)cyclohexanol, for example; treating psychological disorders such as depression, panic attacks, phobias, drug abuse, as well as obesity and bulemia |
| 02/14/2002 | CA2417358A1 Bio-intermediates for use in the chemical synthesis of polyketides |
| 02/13/2002 | EP1178980A1 Salts of 2,2-dimethyl-1,3-dioxane intermediates and process for the preparation thereof |
| 02/13/2002 | EP1178792A1 Aryl amidines, compositions containing such compounds and methods of use |
| 02/13/2002 | EP0873333B1 Phenyl benzyl ethers, process for producing them and their use as pesticide and fungicide |
| 02/07/2002 | US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc. |
| 02/07/2002 | US20020016322 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use |
| 02/07/2002 | US20020015805 Fluoro-substituted alkenyl compounds, liquid crystal compositions, and liquid crystal display elements |
| 02/06/2002 | EP1177169A1 6- [(aryl and heteroaryl)oxy] methyl]naphthalene -2-carboximidamide derivatives, preparation and therapeutic application thereof |
| 02/06/2002 | CN1334798A Phenylglycine derivatives |
| 02/05/2002 | US6344569 Process for producing 6-cyanomethyl-1,3-dioxane-4-acetic acid derivatives |
| 02/05/2002 | US6344558 Analgesics |
| 02/05/2002 | US6344485 Method for treating glaucoma |
| 01/31/2002 | WO2002008215A1 Hyperpolarizable organic chromophores |
| 01/31/2002 | WO2001070682A3 Carbocyclic side chain containing metalloprotease inhibitors |
| 01/31/2002 | DE10035651A1 New dialkyne compounds, used in liquid crystal media, especially in reflective, transflective and electrooptical displays, are cyclohexane compounds or heterocyclic analogues with lateral dialkyne substituent(s) |
| 01/31/2002 | CA2417000A1 Hyperpolarizable organic chromophores |
| 01/30/2002 | EP1175398A1 Indoline derivatives as progesterone antagonists |
| 01/29/2002 | US6342633 O-benzyl oxime ether derivatives and their use as pesticides |
| 01/24/2002 | WO2002006430A1 Marine oils with reduced levels of contaminants |
| 01/24/2002 | WO2002006266A1 Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl)acetic acid derivatives |
| 01/24/2002 | WO2002006213A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 01/24/2002 | WO2002006189A2 Aniline derivatives |
| 01/24/2002 | US20020010343 Compounds having IgE affecting properties |
| 01/24/2002 | US20020010178 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effect |
| 01/24/2002 | US20020009669 Information recording medium and novel oxonol compound |
| 01/24/2002 | US20020009650 High electroconductivity |
| 01/23/2002 | EP1174405A2 Dialkyne compounds |
| 01/23/2002 | EP0833826B1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
| 01/22/2002 | US6340767 Reaction of lithium amide with acetic acid ester and hydroxy propionic acid |
| 01/17/2002 | WO2002004404A2 7,8 and 9-substituted tetracycline compounds |
| 01/17/2002 | US20020007064 For prevention of psychotic disorders such as schizophrenia and other central nervous system diseases |
| 01/17/2002 | CA2415086A1 7,8 and 9-substituted tetracycline compounds |
| 01/16/2002 | CN1330969A Decomposition treatment process for dioxine |
| 01/10/2002 | WO2002002566A1 Therapeutic compounds and methods |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | DE10124480A1 New 4-substituted pentafluorosulfuranylbenzene compounds are used in liquid crystal medium for use in liquid crystal display or as dielectric in electrooptical display |
| 01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
| 01/09/2002 | EP1170352A2 Diflourovinyl compound, liquid crystal composition and liquid crystal display |
| 01/09/2002 | EP1170288A2 Diphenylureum derivatives and their use as alpha2/5-HT2c antagonists |
| 01/09/2002 | EP1170275A2 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application |
| 01/09/2002 | CN1077566C 1-phenyl-3-dimethylaminopropane compounds with pharmacological effect |
| 01/08/2002 | US6337034 Vinylene compounds and liquid-crystal composition |
| 01/03/2002 | WO2002000612A1 Glucagon antagonists/inverse agonists |
| 01/03/2002 | WO2002000607A1 Amide compounds and use thereof |
| 01/03/2002 | WO2002000590A1 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis |
| 01/03/2002 | CA2411552A1 Glucagon antagonists/inverse agonists |
| 01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 01/02/2002 | EP0825189B1 1,4-benzodioxin derivatives |
| 01/02/2002 | CN1077105C Optically active bis-methyldixane derivatives |
| 01/01/2002 | CA2024849C 4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters, process for their preparation, their use as pharmaceuticals, and pharmaceutical preparations and precursors |
| 12/27/2001 | US20010056192 Detected by differential scanning calorimetry; sedimentation; cyclization |
| 12/27/2001 | US20010056117 Oxygen-containing heterocyclic compounds |
| 12/25/2001 | US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation |
| 12/25/2001 | US6333329 Useful for treatment and/or prevention of neuropsychological disorders including schizophrenia, mania, dementia, depression, anxiety, compulsive behavior, drug abuse, parkinson-like motor disorders and motion disorders |
| 12/25/2001 | US6333082 Liquid crystalline (E,E)-butadiene compounds and mixtures and devices containing such compounds |
| 12/20/2001 | WO2001096278A2 A novel process for preparing salmeterol |
| 12/20/2001 | WO2001095856A2 Urea derivative useful as an anti-cancer agent and process for preparing same |
| 12/19/2001 | EP0711270B1 Polymers comprising 4-substituted cyclohexane units |
| 12/18/2001 | US6331641 Process for producing simvastatin |
| 12/18/2001 | US6331602 Monomer and a polymer obtained therefrom |
| 12/18/2001 | CA2152910C Cycloaliphatic acrylic monomer |
| 12/13/2001 | WO2001094337A1 Process for preparing optically active 2-[6-(hydroxy-methyl)-1,3-dioxan-4-yl]acetic acid derivatives |
| 12/13/2001 | WO2001094301A2 Factor viia inhibitory (thio)urea derivatives, their preparation and their use |
| 12/13/2001 | CA2380997A1 Process for preparing optically active 2-¬6-(hydroxy-methyl)-1,3-dioxan-4-yl|acetic acid derivatives |
| 12/12/2001 | EP1162194A1 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
| 12/12/2001 | EP0781126B1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system |
| 12/12/2001 | CN1326473A Supported group 8-10 transition metal olefin polymerization catalysts |
| 12/11/2001 | US6329533 Chemical intermediate for antidiabetic drug |